MIM
ANIP icon

Macroview Investment Management’s ANI Pharmaceuticals ANIP Stock Holding History

Macroview Investment Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-43
Closed -$2.57K – 105
2024
Q3 		$2.57K Hold
43
– – ﹤0.01% 452
2024
Q2 		$2.74K Hold
43
– – ﹤0.01% 455
2024
Q1 		$2.97K Hold
43
– – ﹤0.01% 480
2023
Q4 		$2.37K Sell
43
-149
-78% -$8.21K ﹤0.01% 504
2023
Q3 		$11.1K Sell
192
-7
-4% -$404 0.01% 224
2023
Q2 		$10.7K Buy
+199
New +$8.82K 0.02% 262

Other funds holding ANIP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return